TipRanks
Anbio Biotechnology Class A (NNNN)
NASDAQ:NNNN
US Market
NNNN
Anbio Biotechnology Class A
RESEARCH TOOLSreports

Anbio Biotechnology Class A (NNNN) Revenue

62 Followers
StatisticsMarket CapRevenue

Anbio Biotechnology Class A Revenue

Anbio Biotechnology Class A had a revenue of 4.74M in the quarter ending Dec 31, 2025, with 133.25%. This bring the company's revenue in the last twelve months to 6.77M, Decreased 48.46%. In the fiscal year ending Dec 31, 2025, Anbio Biotechnology Class A had annual revenue of 8.65M with 5.64% growth.
Revenue (ttm)
6.77M
Revenue Growth
10.10%
P/S Ratio
91.69
Revenue/Employee
$320,253
Employees
27
Market Cap
$792.84M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
8.65M461.70K+5.64%
Dec 31, 2024
8.19M1.47M+21.95%
Dec 31, 2023
6.71M-16.83M-71.49%
Dec 31, 2022
23.54M19.12M+431.67%
Dec 31, 2021
4.43M――